Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This study will determine the efficacy, safety, and tolerability of a 40 milligrams (mg) once-daily (QD) dose of LY2940094 for 8 weeks in participants with MDD.
Epistemonikos ID: 9b3959967760b39ceaf4aaa60aca891745fe3dc3
First added on: May 11, 2024